Class 2 Medicines Recall: Lercanidipine Hcl 20mg Tablets, Recordati Industria, El(25)a/17
Lercanidipine HCl 20mg Tablets Recall Summary One batch of Lercanidipine HCl 20mg tablets made by Recordati Pharmaceuticals has incorrect labeling on some sides of the carton, showing "10mg" when the tablets are actually 20mg strength. This labeling error affects patients in the United Kingdom who may be taking this medication for heart conditions.
- Recalling firm
- Lercanidipine HCl 20mg Tablets
- Reason
- Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to one batch of Lercanidipine HCl 20mg Tablets. The packs are incorrectly labelled as 10mg on some sides of the product carton when they are 20mg tablets.
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2025-04-17
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/c15697d1-2647-4336-962d-c78164d6a002